Micha Levy
Impact in
- Toxicology top 0.5%
- Pharmacovigilance and Adverse Drug Reactions
- Nephrology top 2%
- Gout, Hyperuricemia, Uric Acid
Papers in
- Pharmacology 13
- Inflammatory mediators and NSAID effects 5
- Immunology 11
- Immunodeficiency and Autoimmune Disorders 5
- Co-authors
- Eldad Ben‐Chetrit (10 shared papers)Ester Zylber‐Katz (13 shared papers)MARCEL ELIAKIM (5 shared papers)Yoseph Caraco (10 shared papers)Bernd Rosenkranz (1 shared paper)Dennis E. Drayer (3 shared papers)Marcus M. Reidenberg (2 shared papers)David W. Kaufman (4 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (7 papers)The American Journal of the Medical Sciences (3 papers)Seminars in Arthritis and Rheumatism (3 papers)Drug Safety (3 papers)European Journal of Clinical Pharmacology (2 papers)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Micha Levy
55 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 129
- Toxicology 239
- Nephrology 431
- Geriatrics and Gerontology 143
- Pharmacology 284
- Pharmacology 521
Countries citing papers authored by Micha Levy
This map shows the geographic impact of Micha Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Micha Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Micha Levy more than expected).
Fields of papers citing papers by Micha Levy
This network shows the impact of papers produced by Micha Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Micha Levy. The network helps show where Micha Levy may publish in the future.
Co-authors
The 25 scholars most cited alongside Micha Levy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 610 | |
| 2 | 1998 | 291 | |
| 3 | 1974 | 272 | |
| 4 | 1983 | 263 | |
| 5 | 1995 | 186 | |
| 6 | 1975 | 168 | |
| 7 | 1998 | 147 | |
| 8 | 1996 | 146 | |
| 9 | 2000 | 143 | |
| 10 | 1991 | 131 | |
| 11 | 1991 | 122 | |
| 12 | 1979 | 89 | |
| 13 | 1988 | 86 | |
| 14 | 1987 | 82 | |
| 15 | 1984 | 79 | |
| 16 | 2003 | 72 | |
| 17 | 1997 | 60 | |
| 18 | 1996 | 56 | |
| 19 | 1998 | 55 | |
| 20 | 1988 | 54 |
About Micha Levy
Micha Levy is a scholar working on Pharmacology, Immunology, Toxicology, Genetics and Nephrology, having authored 58 papers that have together received 3.9k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (12 papers), Blood disorders and treatments (10 papers), Immunodeficiency and Autoimmune Disorders (5 papers), Pharmacovigilance and Adverse Drug Reactions (5 papers), Inflammatory mediators and NSAID effects (5 papers), Gout, Hyperuricemia, Uric Acid (5 papers), Blood groups and transfusion (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). The work is most often cited by research in Toxicology (239 citations), Nephrology (431 citations), Geriatrics and Gerontology (143 citations), Pharmacology (284 citations) and Pharmacology (521 citations). Micha Levy has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Eldad Ben‐Chetrit, Ester Zylber‐Katz, MARCEL ELIAKIM, Yoseph Caraco, Bernd Rosenkranz, Dennis E. Drayer, Marcus M. Reidenberg, David W. Kaufman, Samuel Shapiro and Liora Granit. Their work appears in journals such as Clinical Pharmacology & Therapeutics, The American Journal of the Medical Sciences, Seminars in Arthritis and Rheumatism, Drug Safety and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.